DCS8 - Clinical Practice Guidelines - Methodology & Dissemination & Implementation Updates

Speaker(s)

• 

  Virginie Blanchette, DPM, PhD (she/her/hers)

  Associate Professor
  Université du Québec à Trois-Rivières
  University of Quebec at Trois-Rivieres
  Québec, Quebec, Canada

  Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose
• 

  Susie Jin, RPh CDE (she/her/hers)

  Pharmacist
  Cobourg, Ontario
  Cobourg, Ontario, Canada

  Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Advisory Board (Terminated, June 21, 2024); Bieiersdorf: Advisory Board (Ongoing); Boehringer Ingelheim: Employment (Terminated, January 10, 2025), Grant/Research Support (Terminated, January 10, 2025); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Kenvue: Speaker/Honoraria (Terminated, April 5, 2025); Moderna: Committee/Planning Member (Terminated, August 30, 2024), Speaker/Honoraria (Terminated, August 30, 2024); Novo Nordisk Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Ontario Pharmacists Association: Speaker/Honoraria (Ongoing); sanofi aventis: Speaker/Honoraria (Terminated, July 12, 2024); Sol-Millenium: Speaker/Honoraria (Ongoing)
• DN

  Daniel Ngui

  Disclosure information not submitted.
• 

  Jeremy Gilbert, Dr

  Endocrinologist
  Sunnybrook Health Sciences Centre
  University of Toronto
  Toronto, Ontario, Canada

  Disclosure(s): Abbott Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Speaker/Honoraria (Ongoing); Bayer Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Speaker/Honoraria (Ongoing); Novo Nordisk Canada Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Moderator(s)

• 

  Zaina Albalawi, MD, MSc, FRCPC

  Endocrinologist, Associate Professor
  Memorial University of Newfoundland
  Memorial University of Newfoundland
  ST. JOHN'S, Newfoundland and Labrador, Canada

  Disclosure(s): Canada Drug Agency: Committee/Planning Member (Ongoing); Canadian Institutes of Health Research (CIHR): Grant/Research Support (Ongoing); CPD Network: Speaker/Honoraria (Terminated, May 10, 2025); Diabetes Canada: Speaker/Honoraria (Ongoing)